Entry of big firms in healthcare space will benefit users: PharmEasy's Siddharth Shah

API Holdings' Siddharth Shah on what’s next for Thyrocare after the PharmEasy deal, API’s existing online drug delivery business, and what he makes of deep-pocketed rivals Reliance and Tata Group. Excerpts from the interview:

from Tech-Economic Times https://ift.tt/3w95E6b